Drug Shortage Report for SODIUM BICARBONATE INJECTION, USP
Report ID | 186632 |
Drug Identification Number | 02486628 |
Brand name | SODIUM BICARBONATE INJECTION, USP |
Common or Proper name | SODIUM BICARBONATE INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM BICARBONATE |
Strength(s) | 42MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 5 mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2024-03-08 |
Estimated end date | Unknown |
Actual end date | 2024-09-10 |
Shortage status | Resolved |
Updated date | 2025-04-08 |
Company comments | Product is discontinued as previously reported. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2025-04-08 | French | Compare |
v6 | 2025-04-08 | English | Compare |
v5 | 2024-04-05 | French | Compare |
v4 | 2024-04-05 | English | Compare |
v3 | 2023-03-10 | French | Compare |
v2 | 2023-03-10 | English | Compare |
v1 | 2023-03-10 | English | Compare |
Showing 1 to 7 of 7